Correlation Between NLR Combined with PLR Score and Prognosis of Hepatocellular Carcinoma After Liver Transplantation
Yishan Niu,Xiaoye Yuan,Fansheng Guo,Jinglin Cao,Yang Wang,Xin Zhao,Jian Dou,Qiang Zeng
DOI: https://doi.org/10.2147/ijgm.s450585
IF: 2.145
2024-05-28
International Journal of General Medicine
Abstract:Yishan Niu, 1 Xiaoye Yuan, 2 Fansheng Guo, 1 Jinglin Cao, 1 Yang Wang, 1 Xin Zhao, 1 Jian Dou, 1 Qiang Zeng 1 1 Department of Hepatobiliary Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, 050051, People's Republic of China; 2 Department of Gerontology, Hebei General Hospital, Shijiazhuang, Hebei, 050051, People's Republic of China Correspondence: Qiang Zeng, Department of Hepatobiliary Surgery, Hebei Medical University Third Hospital, No. 139 Ziqiang Road, Shijiazhuang, Hebei, 050051, People's Republic of China, Email Background: This investigation evaluated the prognostic significance of the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), and introduced a combined NLR-PLR score to evaluate the correlation between NLR-PLR score and hepatocellular carcinoma (HCC) recurrence. Material/Methods: We enrolled 110 patients who underwent orthotopic liver transplantation (LT) for HCC. The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) were assessed, and appropriate cut-off values were established. The NLR-PLR score ranged from 0 to 2 as follows: score of 2, high NLR (≥ 3.37) and high PLR (≥ 105.96); score of 1, either high NLR or high PLR; score of 0, neither high NLR nor high PLR. Results: The median overall survival (OS) of patients with NLR-PLR score of 0, 1 and 2 was 27, 26.5, and 6 months, respectively. The median OS of patients with NLR-PLR score of 2 was shorter than those with 0 ( P < 0.001) and 1 ( P < 0.001). The median disease-free survival (DFS) time of patients with NLR-PLR score of 0, 1 and 2 was 24.5, 24, and 6 months, The median DFS of patients with NLR-PLR score of 2 was shorter than those with 0 ( P = 0.001) and 1 ( P = 0.015). Multivariate analysis showed that NLR-PLR score was an independent risk factor for prognosis and survival. Conclusion: NLR, PLR and NLR-PLR score can predict the long-term survival of patients, and NLR-PLR score, having more predictive value than NLR and PLR alone is an independent risk factor for patient survival. more predictive value than NLR and PLR alone. Keywords: hepatocellular carcinoma, liver transplantation, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, NLR-PLR score, prognosis HCC accounts for 85% to 90% of primary liver cancer, its the sixth most common cancer and the third leading cause of cancer-related deaths worldwide. 1 The treatment of HCC mainly includes radical resection, liver transplantation, radiofrequency ablation, transcatheter arterial chemoembolization (TACE), radiotherapy, and systemic anti-tumor therapy. Studies have shown that in unresectable HCC patients who have not previously received systemic therapy, compared with the standard regimen of sorafenib, PD-L1 immune checkpoint inhibitor Attilizumab (Tecentech) combined with the antiangiogenic drug bevacizumab (Avitine) immunotherapy (" T+A "regimen) improved OS and progression-free survival (PFS). 2–5 In China, many patients with hepatitis B viral (HBV) infection and often combined liver cirrhosis. 6 Liver transplantation is the best treatment plan since it can remove not only the tumor but also the hardening liver. Despite the current use of Milan criteria (MC) and the University of California, San Francisco criteria (UCSF) for patient selection, tumor recurrence is still a major factor limiting the long-term survival of patients, 7 therefore it is urgent to establish other simple and effective selection criteria. At present, studies have pointed out that inflammation is closely related to tumor, and inflammation indicators have been applied to predict the long-term survival of patients after liver transplantation. In this paper, in order to establish a more reasonable and effective prediction method for patients with HCC who need liver transplantation, we calculated NLR and PLR by inflammatory indicators. We combined them to obtain the NLR-PLR score, which was applied to select receptors. There were previous studies on the correlation between inflammatory factors and the prognosis of hepatocellular carcinoma, 8 but they relied on markers that are challenging to obtain and often required invasive examination procedures like pathological biopsy. However, the NLR-PLR score discussed in this study is easy to obtain, non-invasive and highly accepted by patients. In addition, As far as we know, although there have been previous studies on the application of NLR or PLR in liver transplantation for HCC, there is no research on the combination of NLR and PLR to predict the prognosis of liver transplantation patients with HCC. A total of 110 patient -Abstract Truncated-
medicine, general & internal